Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells.

[1]  H. Doerr,et al.  In vitro inhibition of human cytomegalovirus replication by desferrioxamine. , 1994, Antiviral research.

[2]  K. High,et al.  The antimicrobial activities of cyclosporine, FK506, and rapamycin. , 1994, Transplantation.

[3]  K. Stuhlmeier,et al.  Retinoic acid inhibits expression of E-selectin in endothelial cells and prolongs discordant xenograft survival. , 1994, Transplantation Proceedings.

[4]  A. Montag,et al.  Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody. , 1994, Transplantation proceedings.

[5]  M. Sayegh,et al.  Mechanisms of T cell recognition of alloantigen. The role of peptides. , 1994, Transplantation.

[6]  C. Smith,et al.  Adhesion molecules and inflammatory injury , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  B. Markus,et al.  Adhesion and penetration properties of human lymphocytes acting on allogeneic vascular endothelial cells. , 1994, Immunology.

[8]  E. Voest,et al.  Iron-Chelating Agents in Non-Iron Overload Conditions , 1994, Annals of Internal Medicine.

[9]  R. Colvin,et al.  A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. , 1993, Transplantation.

[10]  E. Huang,et al.  Molecular Aspects of Human Cytomegalovirus Diseases , 1993, Frontiers of Virology.

[11]  E. Nakakura,et al.  Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion. , 1993, Transplantation.

[12]  T. Mohanakumar,et al.  Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4. , 1993, Transplantation proceedings.

[13]  N. Sigal,et al.  A single administration of LFA-1 antibody confers prolonged allograft survival. , 1993, Transplantation.

[14]  H. Vinters,et al.  Pathology of Human Cytomegalovirus Infection , 1993 .

[15]  M. Ho.  Cytomegalovirus Infection After Solid Organ Transplantation , 1993 .

[16]  J. Wallwork,et al.  The Management of Cytomegalovirus Infection in Heart-Lung Transplant Recipients , 1993 .

[17]  B. Markus,et al.  Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma. , 1992, Human immunology.

[18]  M. Isobe,et al.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. , 1992, Science.

[19]  Y. Tanaka,et al.  Lymphocyte interactions with endothelial cells. , 1992, Immunology today.

[20]  K. Nouri-Aria,et al.  Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. , 1990, Immunology.

[21]  D. Snydman,et al.  The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products , 1990, Transfusion.

[22]  W. Britt,et al.  Congenital and perinatal cytomegalovirus infections. , 1990, Reviews of infectious diseases.

[23]  R. Rubin.  Impact of cytomegalovirus infection on organ transplant recipients. , 1990, Reviews of infectious diseases.

[24]  S. Todo,et al.  Infections with FK 506 immunosuppression: preliminary results with primary therapy. , 1990, Transplantation proceedings.

[25]  E. Berg,et al.  Inflammation-induced endothelial cell adhesion to lymphocytes, neutrophils, and monocytes. Role of homing receptors and other adhesion molecules. , 1989, Transplantation.

[26]  J. Kupiec-Weglinski,et al.  Lymphocyte Migration Patterns in Organ Allograft Recipients , 1989, Immunological reviews.

[27]  M. Beilke.  Vascular endothelium in immunology and infectious disease. , 1989, Reviews of infectious diseases.

[28]  C. Schacherer,et al.  Rapid (24h) neutralization assay for the detection of antibodies to human cytomegalovirus using a monoclonal antibody to an HCMV early nuclear protein. , 1988, Journal of virological methods.

[29]  J. Barankiewicz,et al.  Impairment of nucleotide metabolism by iron-chelating deferoxamine. , 1987, Biochemical Pharmacology.

[30]  M. V. van Dam-Mieras,et al.  Induction of endothelial cell procoagulant activity by cytomegalovirus infection. , 1987, Thrombosis Research.

[31]  K. Lafferty,et al.  Desferrioxamine Treatment Prevents Chronic Islet Allograft Damage , 1986, Diabetes.

[32]  J. Cambier,et al.  Desferoxamine blocks IL 2 receptor expression on human T lymphocytes. , 1986, Journal of immunology.

[33]  D. Nelson,et al.  Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Romano,et al.  The effect of desferrioxamine on the proliferative response of rat lymphocytes stimulated with various mitogens in vitro. , 1984, Immunopharmacology.

[35]  P. Doherty,et al.  Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent , 1984, The Journal of experimental medicine.

[36]  H. Masur,et al.  Herpesvirus infections in the acquired immune deficiency syndrome. , 1984, JAMA.

[37]  M. Pippard,et al.  THE MANAGEMENT OF IRON CHELATION THERAPY , 1983, British journal of haematology.

[38]  D. Hunting,et al.  Models of the regulation of ribonucleotide reductase and their evaluation in intact mammalian cells. , 1982, CRC critical reviews in biochemistry.

[39]  P. Lietman,et al.  Iron and deferoxamine in lymphocyte blastogenesis. , 1980, Journal of immunopharmacology.

[40]  A. Jacobs,et al.  Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects , 1979, British journal of haematology.

[41]  H. Balfour.  Cytomegalovirus: the troll of transplantation. , 1979, Archives of internal medicine.

[42]  K. Ganeshaguru,et al.  Effect of Iron Deficiency and Desferrioxamine on DNA Synthesis in Human Cells , 1976, British journal of haematology.

[43]  W. Henle,et al.  Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. , 1975, The Journal of infectious diseases.

[44]  D. Flynn,et al.  Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress , 1974, British medical journal.

[45]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[46]  J. Craighead,et al.  Cytomegalovirus infection and cytomegalic inclusion disease in renal homotransplant recipients. , 1966, The American journal of medicine.